NovoCure Ltd — Director's Dealing 2017

Mar 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-03-14

Reporting Person: Perlhagen Gert L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-14	Ordinary Shares	P	125000	$6.93	Acquired	6125000	Direct

Footnotes

F1: On March 14, 2017, Mr. Perlhagen purchased 125,000 shares in multiple trades at prices ranging from $6.825 to $7.05. The price reported above reflects the weighted average purchase price. Mr. Perlhagen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.